GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Forward PE Ratio

OraSure Technologies (FRA:EP3) Forward PE Ratio : 33.85 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies Forward PE Ratio?

OraSure Technologies's Forward PE Ratio for today is 33.85.

OraSure Technologies's PE Ratio without NRI for today is 8.43.

OraSure Technologies's PE Ratio for today is 16.17.


OraSure Technologies Forward PE Ratio Historical Data

The historical data trend for OraSure Technologies's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Forward PE Ratio Chart

OraSure Technologies Annual Data
Trend 2015-12 2016-12 2017-12 2018-12 2019-12 2020-01
Forward PE Ratio
108.70 40.82 47.17 23.04 39.68 38.76

OraSure Technologies Quarterly Data
2015-12 2016-03 2016-06 2016-09 2016-12 2017-03 2017-06 2017-09 2017-12 2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2019-09 2019-12
Forward PE Ratio 108.70 28.74 37.74 45.87 40.82 32.89 48.08 57.14 47.17 35.59 37.45 31.85 23.04 36.76 41.49 22.83 39.68

Competitive Comparison of OraSure Technologies's Forward PE Ratio

For the Medical Instruments & Supplies subindustry, OraSure Technologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's Forward PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's Forward PE Ratio falls into.



OraSure Technologies Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


OraSure Technologies  (FRA:EP3) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


OraSure Technologies Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines